Shares in Adaptive Biotechnologies, backed by Microsoft, Celgene, Illumina, LabCorp and BD Biosciences, soared more than 100% on its first day of trading.

Ladi Greenstreet has left his US-based head of healthcare position at Accenture Ventures to become the unit's head of UK and Ireland.

Encoded Therapeutics, which was incubated in Illumina’s accelerator, has captured $104m in a series C round backed by the corporate’s strategic investment unit, Illumina Ventures.

Cardiovascular drug developer Sanifit raised $82.1m including $62.8m from investors that included existing backer Lundbeckfonden Ventures to bring its overall financing to $149m.

Morphic began trading on the Nasdaq Global Market yesterday after issuing 6 million shares priced at $15 each, providing exits to AbbVie, GSK, Novo, Pfizer, Schrödinger and ShangPharma.

The biomarkers imaging kit maker will use proceeds from the Applied Materials-backed series C round to fund international expansion plans.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Shire and Novo are in line for exits from liver disease startup Mirum Pharmaceuticals, which has filed to raise $86.3m in its IPO.

Frontier Medicines, based on UC Berkeley research, has launched with $67m in series A funding co-led by Deerfield Management, MPM Capital and Droia Oncology Ventures.

NGP Capital invested $20m in the traditional Chinese medicine and healthcare portal, which had previously raised more than $44m from investors including Fosun.